US Patent No. 8,980,638

Use of IMP3 as a prognostic marker for cancer
Apr 24, 2015

University of Massachusetts has been awarded US Patent No. 8,980,638, "Use of IMP3 as a prognostic marker for cancer."

The data generated by 100,000 Genomes Project is being housed on military servers due to attacks by hackers, Naked Security reports.

A new poll finds most US adults are not familiar with personalized medicine, according to HealthDay.

Vox reports that the United Nations' Convention on Biological Diversity decided against a gene drive moratorium.

In Science this week: sequencing of neuroblastomas uncovers alterations linked to prognosis, and more.

Dec
12
Sponsored by
Illumina

This webinar will discuss the use of shotgun metagenomics to identify children at risk of hospital-acquired infection.